Authors
Loading...
This review highlights yttrium-90 SIRT's benefits in improving tumor response in primary hepatocellular carcinoma, suggesting enhanced outcomes through systemic therapy.
Chai et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: